Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) announced that all seven management nominees were re-elected to its board of directors at the company’s annual meeting of shareholders held virtually on June 24, 2026. The directors—Ross R. Bhappu, Michael H. Stirzaker, Barbara A. Filas, Bruce D. Hansen, Jaqueline Herrera, Benjamin Eshleman III, and Dennis L. Higgs—each received strong support, with votes in favor ranging from 88.61% to 99.61% of cast votes, according to the company’s press release.
The re-election is a key indicator of shareholder confidence in Energy Fuels’ strategic direction. As a leading U.S. critical materials company, Energy Fuels specializes in uranium, rare earth elements (REE), heavy mineral sands, vanadium, and the development of medical isotopes. The company has been the top U.S. producer of natural uranium concentrate and owns the only fully licensed conventional uranium mill operating in the country—the White Mesa Mill in Utah. At this mill, Energy Fuels also produces REE products and evaluates medical isotope recovery for emerging cancer therapies.
Energy Fuels is advancing three heavy mineral sands and rare earth projects: the Vara Mada Project in Madagascar, the Bahia Project in Brazil, and the Donald Project in Australia, which is a joint venture with Astron Limited. These projects underscore the company’s commitment to diversifying its critical mineral supply chain outside of China, a strategic priority given the growing demand for materials essential to clean energy technologies and national defense.
The board’s composition reflects a blend of industry expertise and governance experience. For instance, Barbara A. Filas brings environmental and regulatory insights, while Jaqueline Herrera offers financial and international business perspectives. The strong re-election margins suggest that shareholders support the board’s oversight of Energy Fuels’ operations and growth initiatives.
The company’s focus on uranium remains crucial as nuclear power gains traction as a low-carbon energy source. Additionally, Energy Fuels’ rare earth and medical isotope activities align with U.S. government efforts to secure domestic supplies for defense and healthcare. The White Mesa Mill’s capability to recover isotopes like radium-226 for targeted alpha therapy could position Energy Fuels as a key player in the emerging radiopharmaceutical market.
In a broader context, Energy Fuels’ annual meeting results come at a time when critical mineral supply chains are under heightened geopolitical scrutiny. The company’s integrated approach—from mining to processing—offers a vertically integrated model that could reduce reliance on foreign sources. Investors and industry observers will watch how the re-elected board navigates regulatory hurdles, project timelines, and market fluctuations in uranium and rare earth prices.
For more information on Energy Fuels, visit the company’s newsroom at http://nnw.fm/UUUU.
